Dow Jones Industrial Average Futures Signal Rebound

What to Expect After the Pullback From Record Highs

by Celeste Taylor

Published on Sep 14, 2016 at 9:18 AM

Dow Jones Industrial Average (DJIA) futures are signaling a higher start to the day, as stocks look to recover some of yesterday's steep losses. A brief rebound in oil prices also boosted stocks, although October-dated crude has since swung 0.7% lower to $44.61 per barrel, ahead of today's crude inventories report. The recent volatility could continue into next week, as traders speculate on the odds of the Fed hiking interest rates at its highly anticipated September meeting.

Continue reading for more on today's market, including: 

  • What to expect after the pullback from record highs, according to Schaeffer's Senior Quantitative Analyst Rocky White.
  • 3 volatile energy stocks garnering analyst attention.
  • What "crazy" move one activist thinks will turn Tesla Motors Inc (NASDAQ:TSLA) into "a walking insolvency."
  • Plus... Central bank concerns weigh on Japan, the highly anticipated Monsanto merger, and two drugmakers in the spotlight.

160914OV1

Futures on the Dow Jones Industrial Average (DJIA) are about 49 points above fair value.

5 Things You Need to Know Today
 

  1. Japan stocks fell amid central bank concerns.
  2. The Chicago Board Options Exchange (CBOE) saw 703,006 call contracts traded on Tuesday, compared to 529,361 put contracts. The resultant single-session equity put/call ratio rose to 0.75, while the 21-day moving average rose to 0.66.
  3. Monsanto Company (NYSE:MON) is set to open up 0.6%, following the announcement that it had come to a buyout agreement with German pharmaceutical company Bayer AG for about $66 billion. The highly anticipated M&A agreement values MON at approximately $129 per share, or over a 20% premium to its close of $106.10 yesterday.   
  4. In other merger news, Vitae Pharmaceuticals Inc (NASDAQ:VTAE) is set to more than double, following a merger agreement with Allergan plc Ordinary Shares (NYSE:AGN). AGN will buy the company for $639 million, or $21 per share -- a 159% premium to VTAE's closing price of $8.10 yesterday.
  5. Sarepta Therapeutics Inc (NASDAQ:SRPT) is up 13.7% in electronic trading, following news that the Food and Drug Administration's (FDA) most vocal critic of SRPT's eteplirsen -- a drug intended to treat Duchenne Muscular Dystrophy (DMD) -- had left his position at the FDA. Eteplirsen advocates are hoping that Dr. Ronald Farkas' departure is a sign that approval for the drug is forthcoming, ending months of anticipation.

Buzz Stocks Sept 14

Earnings and Economic Data

Today, import and export prices will come out. Cracker Barrel (CBRL) will step up to the earnings stage. To see what else is coming up on this week's schedule, click here

Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check

A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


3 Million to Lose Jobs – and Not Because of Coronavirus?
A terrifying new trend can make you a millionaire or destroy your financial future.
Wall Street Reclaims Two Key Trendlines This Week
U.S.-China tensions and dire economic data still weigh, though
Dell Stock Jumps on Upbeat First Quarter
DELL announced an upbeat first-quarter report
Research Exposes Shortcut to Stock Market Wins
A simple way to stop picking losers, and start cashing in like Wall Street's elite.